[go: up one dir, main page]

WO2009025358A1 - 複素環化合物およびその用途 - Google Patents

複素環化合物およびその用途 Download PDF

Info

Publication number
WO2009025358A1
WO2009025358A1 PCT/JP2008/065011 JP2008065011W WO2009025358A1 WO 2009025358 A1 WO2009025358 A1 WO 2009025358A1 JP 2008065011 W JP2008065011 W JP 2008065011W WO 2009025358 A1 WO2009025358 A1 WO 2009025358A1
Authority
WO
WIPO (PCT)
Prior art keywords
heterocyclic compound
disclosed
formulae
iii
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/065011
Other languages
English (en)
French (fr)
Inventor
Masaaki Hirose
Masanori Okaniwa
Takashi Imada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Priority to JP2009529075A priority Critical patent/JP5270553B2/ja
Priority to EP08827923.7A priority patent/EP2181987B9/en
Priority to US12/674,801 priority patent/US8324395B2/en
Publication of WO2009025358A1 publication Critical patent/WO2009025358A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

　強力なＲａｆ阻害活性を示す複素環化合物を提供すること。式 〔式中、各記号は本文と同意義である。〕で表される化合物またはその塩。
PCT/JP2008/065011 2007-08-23 2008-08-22 複素環化合物およびその用途 Ceased WO2009025358A1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2009529075A JP5270553B2 (ja) 2007-08-23 2008-08-22 複素環化合物およびその用途
EP08827923.7A EP2181987B9 (en) 2007-08-23 2008-08-22 2-Carbonylaminobenzothiazoles and their use for the prophylaxis and treatment of cancer
US12/674,801 US8324395B2 (en) 2007-08-23 2008-08-22 Heterocyclic compound and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-217633 2007-08-23
JP2007217633 2007-08-23

Publications (1)

Publication Number Publication Date
WO2009025358A1 true WO2009025358A1 (ja) 2009-02-26

Family

ID=40378258

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/065011 Ceased WO2009025358A1 (ja) 2007-08-23 2008-08-22 複素環化合物およびその用途

Country Status (4)

Country Link
US (1) US8324395B2 (ja)
EP (1) EP2181987B9 (ja)
JP (1) JP5270553B2 (ja)
WO (1) WO2009025358A1 (ja)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143258B2 (en) 2008-12-02 2012-03-27 Takeda Pharmaceutical Company Limited Benzothiazole compounds useful for Raf inhibition
US8304557B2 (en) 2007-06-05 2012-11-06 Takeda Pharmaceutical Company Limited Fused heterocycle derivatives and use thereof
US8324395B2 (en) 2007-08-23 2012-12-04 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
US8344135B2 (en) 2007-08-29 2013-01-01 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
US8445509B2 (en) 2008-05-08 2013-05-21 Takeda Pharmaceutical Company Limited Fused heterocyclic derivatives and use thereof
US8697874B2 (en) 2008-12-01 2014-04-15 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
JP2014530194A (ja) * 2011-09-14 2014-11-17 ニューファーマ， インコーポレイテッド 特定の化学的実体、組成物、および方法
US10047059B2 (en) 2012-11-12 2018-08-14 Neupharma, Inc. Substituted quinoxalines for inhibiting kinase activity
US10457641B2 (en) 2012-09-24 2019-10-29 Neupharma, Inc. Certain chemical entities, compositions, and methods
US10590106B2 (en) 2012-01-25 2020-03-17 Neupharma, Inc. Certain chemical entities, compositions, and methods

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009111279A1 (en) * 2008-02-29 2009-09-11 Array Biopharma Inc. Pyrazole [3, 4-b] pyridine raf inhibitors
US20110003809A1 (en) * 2008-02-29 2011-01-06 Array Biopharma Inc. Imidazo [4,5-b] pyridine derivatives used as raf inhibitors
JP2011513332A (ja) * 2008-02-29 2011-04-28 アレイ バイオファーマ、インコーポレイテッド 癌の治療のためのｒａｆ阻害剤としてのｎ−（６−アミノピリジン−３−イル）−３−（スルホンアミド）ベンズアミド誘導体
KR20100122505A (ko) * 2008-02-29 2010-11-22 어레이 바이오파마 인크. Ｒａｆ 저해물질 화합물 및 이들의 이용 방법
ES2725790T3 (es) 2011-08-26 2019-09-27 Neupharma Inc Algunas entidades químicas, composiciones, y métodos
WO2013043935A1 (en) 2011-09-21 2013-03-28 Neupharma, Inc. Certain chemical entites, compositions, and methods
US9249111B2 (en) 2011-09-30 2016-02-02 Neupharma, Inc. Substituted quinoxalines as B-RAF kinase inhibitors
CN109053630B (zh) * 2018-08-22 2022-04-01 中国人民解放军第二军医大学 一种苯并噻唑类衍生物及其用途
CN114805120A (zh) * 2022-05-23 2022-07-29 江苏瑞达环保科技有限公司 一种间氰甲基苯甲酸甲酯的合成工艺
CN115724837B (zh) * 2022-10-26 2024-07-23 中国人民解放军海军军医大学 一种抑制程序性细胞坏死的苯并噻唑衍生物及其应用

Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2399026A (en) 1941-02-06 1946-04-23 Chem Ind Basel Amides of 2-aminoarylenethiazoles
WO1999010325A1 (en) 1997-08-06 1999-03-04 Glaxo Group Limited Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
WO2000041698A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
WO2000042012A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
WO2001066540A1 (en) 2000-03-06 2001-09-13 Smithkline Beecham P.L.C. Imidazol-2-carboxamide derivatives as raf kinase inhibitors
WO2001066539A1 (en) 2000-03-06 2001-09-13 Smithkline Beecham P.L.C. Imidazol derivatives as raf kinase inhibitors
WO2002024680A1 (en) 2000-09-21 2002-03-28 Smithkline Beecham P.L.C. Imidazole derivatives as raf kinase inhibitors
WO2002044156A2 (en) 2000-11-29 2002-06-06 Glaxo Group Limited Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
WO2002062763A2 (en) 2001-02-07 2002-08-15 Bayer Corporation Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas
WO2002094808A1 (en) 2001-05-19 2002-11-28 Smithkline Beecham P.L.C. Imidazole-2-carboxamide derivatives as raf kinase inhibitors
WO2003022838A1 (en) 2001-09-05 2003-03-20 Smithkline Beecham Plc Pyridine substituted furan derivatives as raf kinase inhibitors
WO2003022837A1 (en) 2001-09-05 2003-03-20 Smithkline Beecham P.L.C. Heterocycle-carboxamide derivatives as raf kinase inhibitors
WO2003022833A1 (en) 2001-09-05 2003-03-20 Smithkline Beecham Plc Pyridylfurans and pyrroles as raf kinase inhibitors
WO2003022836A1 (en) 2001-09-05 2003-03-20 Smithkline Beecham Plc Nitrogen-containing heterocyclic compounds and their use as raf inhibitors
WO2003074515A1 (en) * 2002-03-01 2003-09-12 Smithkline Beecham Corporation Diamino-pyrimidines and their use as angiogenesis inhibitors
WO2003082272A1 (en) 2002-03-29 2003-10-09 Chiron Corporation Substituted benzazoles and use thereof as raf kinase inhibitors
WO2005032548A1 (en) 2003-09-29 2005-04-14 Chiron Corporation Substituted benzazoles and use thereof as inhibitors of raf kinase
WO2005037273A1 (en) * 2003-10-16 2005-04-28 Chiron Corporation Substituted benzazoles and use thereof as inhibitors of raf kinase
WO2005112932A2 (en) 2004-05-07 2005-12-01 Exelixis, Inc. Raf modulators and methods of use
WO2006076376A1 (en) 2005-01-11 2006-07-20 Medicinova, Inc. Topical treatment of solid tumors and ocular neovascularization
WO2007030377A1 (en) 2005-08-30 2007-03-15 Novartis Ag Substituted benzimidazoles as kinase inhibitors
WO2007121484A2 (en) * 2006-04-19 2007-10-25 Novartis Ag 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096264A (en) 1975-12-09 1978-06-20 Merck & Co., Inc. Certain substituted imidazo [1,2-a] pyridines
CO4950519A1 (es) 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
ES2230719T3 (es) 1997-09-26 2005-05-01 Zentaris Gmbh Compuestos basados en azabencimidazol para modular una funcion de proteina-quinasa de serina/treonina.
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
ATE253051T1 (de) 1999-01-22 2003-11-15 Kirin Brewery Chinolinderivate und chinazolinderivate
AU5570600A (en) 1999-07-01 2001-01-22 Ajinomoto Co., Inc. Heterocyclic compounds and medicinal use thereof
EE05330B1 (et) 1999-11-05 2010-08-16 Astrazeneca Ab Kinasoliini derivaadid kui VEGF-i inhibiitorid
AU2001236698A1 (en) 2000-02-07 2001-08-14 Abbott Gesellschaft Mit Beschrankter Haftung & Company Kommanditgesellschaft 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
US6573293B2 (en) 2000-02-15 2003-06-03 Sugen, Inc. Pyrrole substituted 2-indolinone protein kinase inhibitors
WO2002032872A1 (fr) 2000-10-20 2002-04-25 Eisai Co., Ltd. Composes a noyau aromatique azote
JP3839267B2 (ja) * 2001-03-08 2006-11-01 株式会社ルネサステクノロジ 半導体装置及びそれを用いた通信端末装置
US6919155B2 (en) * 2001-12-27 2005-07-19 Konica Corporation Organic photoreceptor and image forming method
US6845231B2 (en) * 2003-03-24 2005-01-18 Agilent Technologies, Inc. Method facilitating inter-mode handoff
US7893096B2 (en) 2003-03-28 2011-02-22 Novartis Vaccines And Diagnostics, Inc. Use of small molecule compounds for immunopotentiation
DE10334663A1 (de) 2003-07-30 2005-03-10 Merck Patent Gmbh Harnstoffderivate
DE10337942A1 (de) 2003-08-18 2005-03-17 Merck Patent Gmbh Aminobenzimidazolderivate
GB0420719D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
US20060076376A1 (en) * 2004-10-12 2006-04-13 Kemery Michael C Armband light
KR20060079098A (ko) 2004-12-31 2006-07-05 주식회사 엘지생명과학 신규한([1,3]티아졸로[5,4-ｂ]피리딘-2-일)-2-카르복사마이드유도체
WO2007007886A1 (en) 2005-07-11 2007-01-18 Mitsubishi Tanabe Pharma Corporation An oxime derivative and preparations thereof
JP2007049266A (ja) * 2005-08-08 2007-02-22 Olympus Corp 画像撮像装置
GT200600429A (es) 2005-09-30 2007-04-30 Compuestos organicos
KR101259100B1 (ko) * 2005-11-04 2013-04-26 엘지전자 주식회사 Ｏｆｄｍ 또는 ｏｆｄｍａ 무선 이동통신 시스템에서의초기 동기를 위한 신호 전송 방법, 초기 동기 획득 방법 및이동통신용 단말
KR20070052207A (ko) 2005-11-16 2007-05-21 주식회사 엘지생명과학 신규한 ｋｄｒ 억제제
JPWO2008016131A1 (ja) 2006-08-04 2009-12-24 武田薬品工業株式会社 縮合複素環化合物
KR20090047509A (ko) 2006-08-04 2009-05-12 다케다 야쿠힌 고교 가부시키가이샤 융합 헤테로시클릭 유도체 및 이의 용도
KR100824205B1 (ko) * 2006-12-26 2008-04-21 매그나칩 반도체 유한회사 Dmos 트랜지스터 및 그 제조방법
WO2008084873A1 (ja) 2007-01-10 2008-07-17 Mitsubishi Tanabe Pharma Corporation オキシム誘導体
JP4328820B2 (ja) 2007-01-10 2009-09-09 田辺三菱製薬株式会社 医薬組成物
AR066845A1 (es) * 2007-06-05 2009-09-16 Takeda Pharmaceutical Derivados de triazolopiridina e imidazopiridina una composicion farmaceutica que los comprende y su uso en la preparacion de un medicamento para el tratamiento del cancer
EP2181987B9 (en) 2007-08-23 2014-09-03 Takeda Pharmaceutical Company Limited 2-Carbonylaminobenzothiazoles and their use for the prophylaxis and treatment of cancer
EP2184285B1 (en) 2007-08-29 2015-11-04 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
WO2009028655A1 (ja) 2007-08-30 2009-03-05 Takeda Pharmaceutical Company Limited 複素環化合物およびその用途
US8445509B2 (en) * 2008-05-08 2013-05-21 Takeda Pharmaceutical Company Limited Fused heterocyclic derivatives and use thereof
JO3101B1 (ar) * 2008-12-02 2017-09-20 Takeda Pharmaceuticals Co مشتقات بنزوثيازول كعوامل مضادة للسرطان

Patent Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2399026A (en) 1941-02-06 1946-04-23 Chem Ind Basel Amides of 2-aminoarylenethiazoles
WO1999010325A1 (en) 1997-08-06 1999-03-04 Glaxo Group Limited Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
WO2000041698A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
WO2000042012A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
WO2001066540A1 (en) 2000-03-06 2001-09-13 Smithkline Beecham P.L.C. Imidazol-2-carboxamide derivatives as raf kinase inhibitors
WO2001066539A1 (en) 2000-03-06 2001-09-13 Smithkline Beecham P.L.C. Imidazol derivatives as raf kinase inhibitors
WO2002024680A1 (en) 2000-09-21 2002-03-28 Smithkline Beecham P.L.C. Imidazole derivatives as raf kinase inhibitors
WO2002044156A2 (en) 2000-11-29 2002-06-06 Glaxo Group Limited Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
WO2002062763A2 (en) 2001-02-07 2002-08-15 Bayer Corporation Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas
WO2002094808A1 (en) 2001-05-19 2002-11-28 Smithkline Beecham P.L.C. Imidazole-2-carboxamide derivatives as raf kinase inhibitors
WO2003022838A1 (en) 2001-09-05 2003-03-20 Smithkline Beecham Plc Pyridine substituted furan derivatives as raf kinase inhibitors
WO2003022837A1 (en) 2001-09-05 2003-03-20 Smithkline Beecham P.L.C. Heterocycle-carboxamide derivatives as raf kinase inhibitors
WO2003022833A1 (en) 2001-09-05 2003-03-20 Smithkline Beecham Plc Pyridylfurans and pyrroles as raf kinase inhibitors
WO2003022836A1 (en) 2001-09-05 2003-03-20 Smithkline Beecham Plc Nitrogen-containing heterocyclic compounds and their use as raf inhibitors
WO2003074515A1 (en) * 2002-03-01 2003-09-12 Smithkline Beecham Corporation Diamino-pyrimidines and their use as angiogenesis inhibitors
WO2003082272A1 (en) 2002-03-29 2003-10-09 Chiron Corporation Substituted benzazoles and use thereof as raf kinase inhibitors
WO2005032548A1 (en) 2003-09-29 2005-04-14 Chiron Corporation Substituted benzazoles and use thereof as inhibitors of raf kinase
WO2005037273A1 (en) * 2003-10-16 2005-04-28 Chiron Corporation Substituted benzazoles and use thereof as inhibitors of raf kinase
WO2005112932A2 (en) 2004-05-07 2005-12-01 Exelixis, Inc. Raf modulators and methods of use
WO2006076376A1 (en) 2005-01-11 2006-07-20 Medicinova, Inc. Topical treatment of solid tumors and ocular neovascularization
WO2007030377A1 (en) 2005-08-30 2007-03-15 Novartis Ag Substituted benzimidazoles as kinase inhibitors
WO2007121484A2 (en) * 2006-04-19 2007-10-25 Novartis Ag 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
CURRENT PHARMACEUTICAL DESIGN, vol. 8, 2000, pages 2269 - 2278
HASEGAWA M. ET AL: "Discovery of novel benzimidazoles as potent inhibitors of TIE2 and VEGFR-2 tyrosine kinase receptors", J. MED. CHEM., vol. 50, no. 18, 8 April 2007 (2007-04-08), pages 4453 - 4470, XP002513776 *
HIGH PERFORMANCE POLYMERS, vol. 8, no. 2, 1996, pages 307 - 314
INDIAN JOURNAL OF CHEMISTRY, SECTION B: ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, vol. 29B, no. 5, 1990, pages 464 - 70
INDIAN JOURNAL OF CHEMISTRY, SECTION B: ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, vol. 30B, no. 5, 1991, pages 494 - 8
INDIAN JOURNAL OF CHEMISTRY, SECTION B: ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, vol. 32B, no. 10, 1993, pages 1035 - 44
J. AM. CHEM. SOC., vol. 116, 1994, pages 5969 - 5970
J. AM. CHEM. SOC., vol. 116, 1994, pages 7901 - 7902
PURE APPL. CHEM., vol. 71, no. 8, 1999, pages 1417 - 1423
See also references of EP2181987A4 *
SKEHAN ET AL., JOURNAL OF NATIONAL CANCER INSTITUTE, vol. 82, 1990, pages 1107 - 1112
YAKUGAKU ZASSHI, vol. 78, 1958, pages 482 - 5
ZEITSCHRIFT FUER NATURFORSCHUNG, C: JOURNAL OF BIOSCIENCES, vol. 45, no. 11-12, 1990, pages 1210 - 14

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8304557B2 (en) 2007-06-05 2012-11-06 Takeda Pharmaceutical Company Limited Fused heterocycle derivatives and use thereof
US8324395B2 (en) 2007-08-23 2012-12-04 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
US8344135B2 (en) 2007-08-29 2013-01-01 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
US8445509B2 (en) 2008-05-08 2013-05-21 Takeda Pharmaceutical Company Limited Fused heterocyclic derivatives and use thereof
US8697874B2 (en) 2008-12-01 2014-04-15 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
US8497274B2 (en) 2008-12-02 2013-07-30 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
US8143258B2 (en) 2008-12-02 2012-03-27 Takeda Pharmaceutical Company Limited Benzothiazole compounds useful for Raf inhibition
JP2014530194A (ja) * 2011-09-14 2014-11-17 ニューファーマ， インコーポレイテッド 特定の化学的実体、組成物、および方法
JP2017082011A (ja) * 2011-09-14 2017-05-18 ニューファーマ， インコーポレイテッド 特定の化学的実体、組成物、および方法
US10065932B2 (en) 2011-09-14 2018-09-04 Neupharma, Inc. Certain chemical entities, compositions, and methods
US10759766B2 (en) 2011-09-14 2020-09-01 Neupharma, Inc. Certain chemical entities, compositions, and methods
US10590106B2 (en) 2012-01-25 2020-03-17 Neupharma, Inc. Certain chemical entities, compositions, and methods
US10457641B2 (en) 2012-09-24 2019-10-29 Neupharma, Inc. Certain chemical entities, compositions, and methods
US10047059B2 (en) 2012-11-12 2018-08-14 Neupharma, Inc. Substituted quinoxalines for inhibiting kinase activity

Also Published As

Publication number Publication date
US20110172245A1 (en) 2011-07-14
JPWO2009025358A1 (ja) 2010-11-25
EP2181987A1 (en) 2010-05-05
EP2181987B9 (en) 2014-09-03
EP2181987B1 (en) 2014-03-05
US8324395B2 (en) 2012-12-04
EP2181987A4 (en) 2012-03-07
JP5270553B2 (ja) 2013-08-21

Similar Documents

Publication Publication Date Title
WO2009025358A1 (ja) 複素環化合物およびその用途
WO2009028655A1 (ja) 複素環化合物およびその用途
WO2009028629A1 (ja) 複素環化合物およびその用途
WO2009030469A8 (en) Fungicidal 2-alkylthio-2-quinolinyloxy-acetamide deritvatives
WO2009048101A1 (ja) アミド化合物
TN2011000280A1 (en) Benzothiazole derivatives as anticancer agents
WO2009049716A8 (en) Novel fungicides
WO2008130021A3 (en) Heterocyclic hydrazide compound and pesticidal use of the same
WO2008110355A8 (en) Quinoline derivatives as fungicides
EP1953145A4 (en) HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY OF 11-HYDROXYSTEROID DEHYDROGENASE TYPE I
WO2009019015A8 (en) Novel herbicides
WO2009051244A1 (ja) 複素環化合物
WO2008122375A3 (en) Insecticidal aryl isoxazoline derivatives
WO2009087098A3 (en) Quinoline derivatives and their use as fungicides
WO2008123469A1 (ja) ６員環アミド化合物およびその用途
WO2010063700A8 (en) Novel pyrazole-4 -n-alkoxycarboxamides as microbiocides
WO2009077443A3 (de) Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
WO2009060835A8 (ja) 新規ユビキリン結合性小分子
WO2008102908A1 (ja) ハロアルキルスルホンアニリド誘導体
WO2006058700A8 (en) Acetamide compounds as fungicides
WO2009041705A3 (en) 5-membered heterocyclic compounds as proton pump inhibitors
WO2009077500A3 (de) Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
WO2009019005A3 (en) Tricyclic bridged cyclopentanedione derivatives as herbicides
WO2008151828A3 (en) Novel microbiocides
WO2009007115A8 (en) Tropane derivatives useful as pesticides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08827923

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009529075

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12674801

Country of ref document: US

Ref document number: 2008827923

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE